MedPath

Antimicrobial Hernia Repair Device Clinical Study

Not Applicable
Completed
Conditions
Ventral Hernia
Incisional Hernia
Registration Number
NCT02401334
Lead Sponsor
Cook Group Incorporated
Brief Summary

This prospective clinical study will evaluate the safety and efficacy of the Cook® Antimicrobial Hernia Repair Device containing an antimicrobial to reinforce soft tissue during ventral or incisional hernia repair in clean-contaminated, contaminated, and dirty-infected (i.e., Class II, Class III, and Class IV) surgical fields. Up to 30 patients will be treated with the Cook® Antimicrobial Hernia Repair Device and patients will be followed for 12 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Patient presents with a ventral or incisional hernia that is to be surgically corrected using open repair technique
Exclusion Criteria
  • Body Mass Index (BMI) < 25.
  • Body weight < 45 kg
  • Glycosylated Hemoglobin (Hgb A1c) > 10%
  • Albumin < 2.5 g/dL or pre-albumin < 5.0 mg/dL
  • Renal insufficiency, as determined by an estimated glomerular filtration rate (GFR) < 60 mL/min/1.73 m2
  • Known allergies to study device components
  • Other relevant exclusion criteria apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Incidence of Surgical Site Infection6 months
Secondary Outcome Measures
NameTimeMethod
Incidence of procedural or post-operative adverse events related to the study device or procedure (i.e., Permanence of hernia repair, as determined by hernia recurrence).12 months

Trial Locations

Locations (4)

St. Paul's Hospital

🇨🇦

Vancouver, British Columbia, Canada

Queen Elizabeth II Health Sciences Centre

🇨🇦

Halifax, Nova Scotia, Canada

Salford Royal Hospital

🇬🇧

Salford, England, United Kingdom

Royal Liverpool Hospital

🇬🇧

Liverpool, United Kingdom

St. Paul's Hospital
🇨🇦Vancouver, British Columbia, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.